Clinics and research in hepatology and gastroenterology
-
Clin Res Hepatol Gastroenterol · Dec 2015
Survival in relation to hospital type after resection or sorafenib treatment for hepatocellular carcinoma in The Netherlands.
Despite an increase in recent years, hepatocellular carcinoma remains uncommon in the Netherlands. The aim of the current study is to explore potential effects of hospital type and volume on outcomes after resection or sorafenib in patients with hepatocellular carcinoma. ⋯ In low incidence countries, outcome after resection or sorafenib for hepatocellular carcinoma may differ between various hospital types.